CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by educational grants from Bristol-Myers Squibb and Lilly USA, LLC.
Target Audience: The intended audience for this activity is rheumatologists and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:
- Examine the underlying principles of innate and adaptive immunity as they contribute to the pathophysiologic basis of rheumatic diseases and the mechanisms of action of available and emerging immune-based therapies.
- Select treatment for patients with RA based on the latest clinical evidence as well as patient characteristics, preferences and prognosis.
- Utilize evidence-based strategies to assess disease activity and alter therapy accordingly for patients with RA.
- Implement strategies to mitigate risk from biologic and immune-based therapies.
Activity Chair:
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Steering Committee:
William F.C. Rigby, MD
Professor of Medicine, Microbiology, and Immunology
Dartmouth Geisel School of Medicine
Hanover, NH
Vibeke Strand, MD, MACR, FACP
Biopharmaceutical Consultant
Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University School of Medicine
Palo Alto, CA
John R. P. Tesser, MD
Adjunct Clinical Professor
Midwestern University College of Health Sciences
Arizona Arthritis and Rheumatology Associates, P.C.
Phoenix, AZ
Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, January 16, 2018 to January 15, 2019.
How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must complete the pretest, review the content, and complete the posttest and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, faculty, reviewers, and staff involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
Activity Chair and Steering Committee report the following relationship(s):
Leonard H. Calabrese, DO
Consulting Fee: Amgen; GlaxoSmithKline; Horizon; Janssen; Pfizer; Regeneron; Sanofi; UCB
Speakers Bureau: AbbVie; Bristol-Myers Squibb; Crescendo; Genentech; Janssen; UCB
William F.C. Rigby, MD
Consulting Fee: Bristol-Myers Squibb; Merck; Pfizer; Roche
Vibeke Strand, MD, MACR, FACP
Consulting Fee: AbbVie; Alder; Amgen; Anthera; Asana; AstraZeneca; aTyr; Bayer; Biogen Idec; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Celltrion; CORRONA; Crescendo/Myriad Genetics; EMD Serono; Eupraxia; Fidia; Flexion; Genentech/Roche; GlaxoSmithKline; Horizon; Iroko; Janssen; Jazz Pharmaceuticals; Kezar; Kypha; Lilly; Merck; Novartis; Pfizer; Protagen; Regeneron; Royalty; RRD; Samsung; Samumed; Sandoz; Sanofi; SKK; UCB
Advisory Board: AbbVie; Amgen; Anthera; AstraZeneca; Biogen Idec; Bayer; Bristol-Myers Squibb; Celltrion; Crescendo; EMD Serono; Fidia; Genentech/Roche; GlaxoSmithKline; Horizon; Iroko; Janssen; Jazz Pharmaceuticals; Lilly; Merck; Novartis; Pfizer; Protagen; Regeneron; Samsung; Sandoz; Sanofi; UCB
John R. P. Tesser, MD
Salary (spouse): Regeneron
Consulting Fee: Amgen; Bristol-Myers Squibb; Crescendo Biosciences/Mallinkrodt; Genentech; Janssen; Lilly; Medac; Pfizer; Sanofi Genzyme and Regeneron; UCB
Speakers Bureau: AbbVie; Amgen; Bristol-Myers Squibb; Crescendo Biosciences; Genentech; Janssen; Lilly; Medac; Pfizer; UCB
Contracted Research: AbbVie; Ablynx; Amgen; AstraZeneca; Bristol-Myers Squibb; Boehringer-Ingelheim; Celgene; Genentech; GlaxoSmithKline; Janssen; Lilly; Merck; Novartis; Pfizer; Sandoz; Sun Pharma; UCB
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com